Description: Phoenix Life Sciences International Limited operates as a healthcare solutions company in the United States and internationally. The company focuses on advancing research, integrating programs, and manufacturing of products that target and treat diabetes, pain, and cancers, as well as address psychological, gastrointestinal, autoimmune, neurological, and sleep disorders. It offers oral soft gel capsules, thin film dissolvable strips, transdermal patches, sublingual oral sprays, suppositories, and topical creams. The company was formerly known as Stem Bioscience, Inc. and changed its name to Phoenix Life Sciences International Limited in May 2018. Phoenix Life Sciences International Limited was incorporated in 2009 and is headquartered in Las Vegas Nevada.
Home Page: www.phoenixlife.co
4262 Blue Diamond Road
Las Vegas,
NV
89139
United States
Phone:
720 699 7222
Officers
| Name | Title |
|---|---|
| Mr. Lewis A. Humer Jr. | Non-Exec. Chairman, Advisor & Director of Corp. |
| Mr. Geoffrey K. Boynton B.Sc. | CFO, Sec. & Director |
| Ms. Janelle L. Marsden | MD & Director |
| Mr. Willis Victory | Chief Exec. Officer |
| Mr. Stephen G. Cornford | Advisor, Director of Investment & Audit and Director |
| Mr. John M. Taleo | Global Head of Security |
| Dr. Santus Wari | National Head of Healthcare in the Republic of Vanuatu |
| Mr. Tekon Timothy Tumukon | Head of Biosecurity Services |
| Dr. Roni Marie Deluz Ph.D., R.N. | Chief Medical Officer and Head of Research & Education Awareness |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.0363 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | February |
| Full Time Employees: | 5 |